Zhang Xu, Wang Sheng, Cheng Guohui, Yu Peng, Chang Jin, Chen Xiaoyuan
School of Life Sciences, Tianjin University and Tianjin Engineering Center of Micro-Nano Biomaterials and Detection-Treatment Technology, Tianjin 300072, China.
Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore, 117597, Singapore.
Matter. 2021 Jan;4(1):26-53. doi: 10.1016/j.matt.2020.10.002. Epub 2021 Jan 6.
Chemotherapy serves as one of the most effective approaches in numerous tumor treatments but also suffers from the limitations of low bioavailability and adverse side effects due to premature drug leakage. Therefore, it is crucial to realize accurate on-demand drug release for promoting the application of chemotherapeutic agents. To achieve this, stimuli-responsive nanomedicines that can be activated by delicately designed cascade reactions have been developed in recent years. In general, the nanomedicines are triggered by an internal or external stimulus, generating an intermediate stimulus at tumor site, which can intensify the differences between tumor and normal tissues; the drug release process is then further activated by the intermediate stimulus. In this review, the latest progress made in cascade reactions-driven drug-release modes, based on the intermediate stimuli of heat, hypoxia, and reactive oxygen species, is systematically summarized. The perspectives and challenges of cascade strategy for drug delivery are also discussed.
化疗是众多肿瘤治疗中最有效的方法之一,但由于药物过早泄漏,存在生物利用度低和副作用大的局限性。因此,实现精确的按需药物释放对于促进化疗药物的应用至关重要。为了实现这一目标,近年来已开发出可通过精心设计的级联反应激活的刺激响应型纳米药物。一般来说,纳米药物由内部或外部刺激触发,在肿瘤部位产生中间刺激,这可以加剧肿瘤组织与正常组织之间的差异;然后,中间刺激进一步激活药物释放过程。在这篇综述中,系统地总结了基于热、缺氧和活性氧等中间刺激的级联反应驱动药物释放模式的最新进展。还讨论了级联给药策略的前景和挑战。